Y-Intercept (HK)’s PDS Biotechnology PDSB Stock Holding History

Y-Intercept (HK)’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-45,883	Closed	-$134K	–	1677
2024 Q2	$134K	Buy	+45,883	New	+$147K	0.01%	1228

Other funds holding PDSB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Y-Intercept (HK)'s PDSB Position: Q3 2024 in Review

Y-Intercept (HK) sold out of PDS Biotechnology (PDSB) in Q3 2024, closing a stake of 45,883 shares — an estimated $134K sold.

Y-Intercept (HK) first reported a position in PDSB in Q2 2024 and held it in 1 quarter. The position peaked at $134K in Q2 2024. 57 funds tracked by Wall St. Rank hold PDSB as of Q3 2024.

Y-Intercept (HK) reported no remaining PDS Biotechnology position as of Q3 2024 after selling out during the quarter.
Y-Intercept (HK) sold 45,883 PDS Biotechnology shares in Q3 2024, an estimated $134K.
Y-Intercept (HK) first reported a position in PDS Biotechnology in Q2 2024 and held it in 1 quarter.
Y-Intercept (HK)'s PDS Biotechnology position peaked at $134K in Q2 2024.
57 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.